Is GRADE being adopted for the assessment of cost-effectiveness evidence?

J. Hayre, P. Kandaswamy & M. Dzingina
Background: The use of cost-effectiveness estimates is increasingly being incorporated into decision making for health. NICE recommends the use of a ‘modified’ GRADE profile for assessing cost-effectiveness evidence in clinical guidelines. Various other GRADE inspired profiles have also[for full text, please go to the a.m. URL]